Sitagliptin as a Novel Treatment Agent for Non-Alcoholic Fatty Liver Disease Patients with Type 2 Diabetes Mellitus
Year: 2011
Type: article
Study design: Clinical Trial
Source: Hepatogastroenterology
DOI: 10.5754/hge11263
Institution: Yokohama City University
Language: English
Subfield: Hepatology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2026049223
